{
    "medicine_id": "188b5c6898366547802f7fd7e1c9faa391355958",
    "platform_id": "DB05464",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v NOX 700",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in diabetes mellitus type 2",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NOX 700 is an orally active nitric oxide NO blocking agent in development for the treatment of diabetes mellitus type 2 In animal studies NOX 700 lowered serum glucose improved glucose tolerance and reduced the percentage of total glycated hemoglobin Immunohistochemical studies on pancreatic tissue also showed that NOX 700 therapy effectively preserved islet structure and increased insulin immunoreactivity It has since been found that oxidative signaling of the redox sensitive transcription factor NF \u03baB and inhibiting protein glycation are responsible for the drug s therapeutic effects",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}